2022
DOI: 10.1016/j.cancergen.2021.12.006
|View full text |Cite
|
Sign up to set email alerts
|

t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Previous literature supports the role of several of these genes as oncogenic drivers in AML. For instance, the ETV6ACSL6 rearrangement has been implicated in the pathogenesis of leukemia [ 30 ]. The activation of the MAP3K1 kinase has been implicated as a contributing factor in the pathogenesis of various malignant neoplasms, rendering it a prospective therapeutic target, particularly in the context of acute myeloid leukemia (AML) [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Previous literature supports the role of several of these genes as oncogenic drivers in AML. For instance, the ETV6ACSL6 rearrangement has been implicated in the pathogenesis of leukemia [ 30 ]. The activation of the MAP3K1 kinase has been implicated as a contributing factor in the pathogenesis of various malignant neoplasms, rendering it a prospective therapeutic target, particularly in the context of acute myeloid leukemia (AML) [ 31 ].…”
Section: Discussionmentioning
confidence: 99%